| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
8,058 |
7,726 |
$2.00M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
6,383 |
6,224 |
$1.61M |
| G0378 |
Hospital observation service, per hour |
432 |
399 |
$441K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
940 |
858 |
$186K |
| X0621 |
|
275 |
211 |
$79K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
280 |
277 |
$72K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
299 |
295 |
$35K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
232 |
225 |
$32K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,103 |
3,505 |
$12K |
| 80053 |
Comprehensive metabolic panel |
2,457 |
2,175 |
$11K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
300 |
295 |
$9K |
| 76830 |
Ultrasound, transvaginal |
141 |
137 |
$9K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
246 |
161 |
$7K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
86 |
86 |
$7K |
| 70450 |
Computed tomography, head or brain; without contrast material |
207 |
193 |
$6K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,384 |
1,170 |
$6K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
190 |
173 |
$5K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
101 |
99 |
$5K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
175 |
161 |
$5K |
| 87631 |
|
83 |
81 |
$5K |
| 71046 |
Radiologic examination, chest; 2 views |
349 |
344 |
$5K |
| T1015 |
Clinic visit/encounter, all-inclusive |
249 |
159 |
$5K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
367 |
290 |
$5K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
14 |
12 |
$4K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
83 |
81 |
$4K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
268 |
255 |
$4K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
610 |
508 |
$3K |
| 84484 |
|
717 |
609 |
$3K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
30 |
30 |
$3K |
| 76642 |
|
43 |
43 |
$2K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
535 |
508 |
$2K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,464 |
1,412 |
$2K |
| 84703 |
|
296 |
282 |
$2K |
| 83735 |
|
673 |
507 |
$1K |
| 71045 |
Radiologic examination, chest; single view |
551 |
510 |
$1K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
14 |
12 |
$1K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
108 |
103 |
$1K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
61 |
59 |
$1K |
| 81001 |
|
695 |
646 |
$1K |
| 72110 |
|
41 |
39 |
$1K |
| 85610 |
|
456 |
423 |
$956.86 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
222 |
206 |
$759.47 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
378 |
334 |
$705.06 |
| 82248 |
|
268 |
246 |
$698.39 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
33 |
31 |
$698.11 |
| J3490 |
Unclassified drugs |
564 |
403 |
$644.32 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
91 |
63 |
$596.13 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,547 |
2,221 |
$530.03 |
| 85730 |
|
173 |
164 |
$517.54 |
| 83690 |
|
247 |
233 |
$511.95 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
493 |
424 |
$503.27 |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
12 |
12 |
$460.91 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
93 |
91 |
$432.83 |
| J2704 |
Injection, propofol, 10 mg |
519 |
454 |
$414.60 |
| 73564 |
|
12 |
12 |
$371.18 |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
14 |
13 |
$338.03 |
| 83880 |
|
41 |
39 |
$317.18 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
327 |
264 |
$233.71 |
| 82550 |
|
66 |
58 |
$220.03 |
| 73630 |
|
28 |
24 |
$215.11 |
| 84443 |
Thyroid stimulating hormone (TSH) |
30 |
30 |
$213.03 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
970 |
864 |
$199.69 |
| J7050 |
Infusion, normal saline solution, 250 cc |
853 |
528 |
$184.59 |
| 86900 |
|
54 |
52 |
$177.15 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,246 |
1,136 |
$173.20 |
| 73030 |
|
13 |
12 |
$170.76 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
281 |
247 |
$146.78 |
| 82962 |
|
181 |
121 |
$136.09 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
27 |
26 |
$107.54 |
| 81003 |
|
99 |
93 |
$105.14 |
| 86901 |
|
27 |
25 |
$71.95 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
289 |
252 |
$66.74 |
| 85379 |
|
29 |
25 |
$63.60 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
255 |
245 |
$63.52 |
| 94760 |
|
64 |
50 |
$46.25 |
| 83605 |
|
14 |
12 |
$26.88 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
131 |
114 |
$13.59 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
152 |
139 |
$12.25 |
| J1644 |
Injection, heparin sodium, per 1000 units |
18 |
12 |
$9.11 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
58 |
44 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
173 |
144 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
14 |
13 |
$0.00 |
| 00000 |
|
861 |
303 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
15 |
12 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
14 |
13 |
$0.00 |